Entyvio 300mg infusion 1 vial

$3,999.00

Quantity Price
1 - 5 $3,999.00
6 - 10 $3,989.00
11 - 20 $3,984.00
21+ $3,979.00

Product information

Brand

Manufacturer

Takeda

Active substance

Vedolizumab

Strength

300mg

Pack size

1-300 mg vial

Description

To treat adult patients with ulcerative colitis and Crohn’s disease utilize Entyvio. It is an integrin receptor antagonist. This product is manufactured by Takeda Pharmaceuticals, a Japanese pharmaceutical company. Entyvio is used for injection and supplied in a single-dose vial for injection.